The Market Reports

Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com

Global Targeting DNA Repair Drugs Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2029

Global Targeting DNA Repair Drugs Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2029

Publishing Date : Jul, 2023

License Type :
 

Report Code : 1755833

No of Pages : 101

Ask Your Query

Synopsis
The global Targeting DNA Repair Drugs market size was valued at USD 615.3 million in 2022 and is forecast to a readjusted size of USD 1629.7 million by 2029 with a CAGR of 14.9% during review period.

DNA damage leads to the incorporation of defects and aberrations in the genome that often result in functional mutations. When these mutations occur in genes coding for vital proteins and/or enzymes, it leads to the development of genetic diseases.

However, our biological system is equipped with a robust repair mechanism capable of correcting damaged DNA sequences.

PARP inhibitors and other similar therapeutics are designed to augment the body’s innate DNA repair mechanism and aid in the treatment of diseases associated with genetic aberrations. This report mainly focuses on targeting DNA repair drugs market.

In 2022, Asia-Pacific holds highest share in targeting DNA repair drugs .

The Global Info Research report includes an overview of the development of the Targeting DNA Repair Drugs industry chain, the market status of Ovarian Cancer (Olaparib, Rucaparib), Fallopian Tube Cancer (Olaparib, Rucaparib), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Targeting DNA Repair Drugs.

Regionally, the report analyzes the Targeting DNA Repair Drugs markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global Targeting DNA Repair Drugs market, with robust domestic demand, supportive policies, and a strong manufacturing base.

Key Features:

The report presents comprehensive understanding of the Targeting DNA Repair Drugs market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the Targeting DNA Repair Drugs industry.

The report involves analyzing the market at a macro level:

Market Sizing and Segmentation: Report collect data on the overall market size, including the sales quantity (K Units), revenue generated, and market share of different by Type (e.g., Olaparib, Rucaparib).

Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the Targeting DNA Repair Drugs market.

Regional Analysis: The report involves examining the Targeting DNA Repair Drugs market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.

Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the Targeting DNA Repair Drugs market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.

The report also involves a more granular approach to Targeting DNA Repair Drugs:

Company Analysis: Report covers individual Targeting DNA Repair Drugs manufacturers, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.

Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards Targeting DNA Repair Drugs This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Ovarian Cancer, Fallopian Tube Cancer).

Technology Analysis: Report covers specific technologies relevant to Targeting DNA Repair Drugs. It assesses the current state, advancements, and potential future developments in Targeting DNA Repair Drugs areas.

Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the Targeting DNA Repair Drugs market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.

Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.

Market Segmentation

Targeting DNA Repair Drugs market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.

Market segment by Type

  • Olaparib
  • Rucaparib
  • Niraparib
  • Talazoparib
  • Others

Market segment by Application

  • Ovarian Cancer
  • Fallopian Tube Cancer
  • Peritoneal Cancer
  • Breast Cancer
  • Others

Major players covered

  • Onxeo
  • FoRx Therapeutics
  • Artios Pharma Limited
  • Merck KGaA
  • Breakpoint Therapeutics
  • Luciole Pharmaceuticals
  • AstraZeneca
  • AbbVie
  • Johnson & Johnson
  • Pfizer
  • ClovisOncology
  • GlaxoSmithKline

Market segment by region, regional analysis covers

  • North America (United States, Canada and Mexico)
  • Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
  • Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
  • South America (Brazil, Argentina, Colombia, and Rest of South America)
  • Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)

The content of the study subjects, includes a total of 15 chapters:

Chapter 1, to describe Targeting DNA Repair Drugs product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Targeting DNA Repair Drugs, with price, sales, revenue and global market share of Targeting DNA Repair Drugs from 2018 to 2023.
Chapter 3, the Targeting DNA Repair Drugs competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Targeting DNA Repair Drugs breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2018 to 2029.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2018 to 2029.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2022.and Targeting DNA Repair Drugs market forecast, by regions, type and application, with sales and revenue, from 2024 to 2029.
Chapter 12, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War.
Chapter 13, the key raw materials and key suppliers, and industry chain of Targeting DNA Repair Drugs.
Chapter 14 and 15, to describe Targeting DNA Repair Drugs sales channel, distributors, customers, research findings and conclusion.

Index

1 Market Overview
1.1 Product Overview and Scope of Targeting DNA Repair Drugs
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global Targeting DNA Repair Drugs Consumption Value by Type: 2018 Versus 2022 Versus 2029
1.3.2 Olaparib
1.3.3 Rucaparib
1.3.4 Niraparib
1.3.5 Talazoparib
1.3.6 Others
1.4 Market Analysis by Application
1.4.1 Overview: Global Targeting DNA Repair Drugs Consumption Value by Application: 2018 Versus 2022 Versus 2029
1.4.2 Ovarian Cancer
1.4.3 Fallopian Tube Cancer
1.4.4 Peritoneal Cancer
1.4.5 Breast Cancer
1.4.6 Others
1.5 Global Targeting DNA Repair Drugs Market Size & Forecast
1.5.1 Global Targeting DNA Repair Drugs Consumption Value (2018 & 2022 & 2029)
1.5.2 Global Targeting DNA Repair Drugs Sales Quantity (2018-2029)
1.5.3 Global Targeting DNA Repair Drugs Average Price (2018-2029)
2 Manufacturers Profiles
2.1 Onxeo
2.1.1 Onxeo Details
2.1.2 Onxeo Major Business
2.1.3 Onxeo Targeting DNA Repair Drugs Product and Services
2.1.4 Onxeo Targeting DNA Repair Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.1.5 Onxeo Recent Developments/Updates
2.2 FoRx Therapeutics
2.2.1 FoRx Therapeutics Details
2.2.2 FoRx Therapeutics Major Business
2.2.3 FoRx Therapeutics Targeting DNA Repair Drugs Product and Services
2.2.4 FoRx Therapeutics Targeting DNA Repair Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.2.5 FoRx Therapeutics Recent Developments/Updates
2.3 Artios Pharma Limited
2.3.1 Artios Pharma Limited Details
2.3.2 Artios Pharma Limited Major Business
2.3.3 Artios Pharma Limited Targeting DNA Repair Drugs Product and Services
2.3.4 Artios Pharma Limited Targeting DNA Repair Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.3.5 Artios Pharma Limited Recent Developments/Updates
2.4 Merck KGaA
2.4.1 Merck KGaA Details
2.4.2 Merck KGaA Major Business
2.4.3 Merck KGaA Targeting DNA Repair Drugs Product and Services
2.4.4 Merck KGaA Targeting DNA Repair Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.4.5 Merck KGaA Recent Developments/Updates
2.5 Breakpoint Therapeutics
2.5.1 Breakpoint Therapeutics Details
2.5.2 Breakpoint Therapeutics Major Business
2.5.3 Breakpoint Therapeutics Targeting DNA Repair Drugs Product and Services
2.5.4 Breakpoint Therapeutics Targeting DNA Repair Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.5.5 Breakpoint Therapeutics Recent Developments/Updates
2.6 Luciole Pharmaceuticals
2.6.1 Luciole Pharmaceuticals Details
2.6.2 Luciole Pharmaceuticals Major Business
2.6.3 Luciole Pharmaceuticals Targeting DNA Repair Drugs Product and Services
2.6.4 Luciole Pharmaceuticals Targeting DNA Repair Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.6.5 Luciole Pharmaceuticals Recent Developments/Updates
2.7 AstraZeneca
2.7.1 AstraZeneca Details
2.7.2 AstraZeneca Major Business
2.7.3 AstraZeneca Targeting DNA Repair Drugs Product and Services
2.7.4 AstraZeneca Targeting DNA Repair Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.7.5 AstraZeneca Recent Developments/Updates
2.8 AbbVie
2.8.1 AbbVie Details
2.8.2 AbbVie Major Business
2.8.3 AbbVie Targeting DNA Repair Drugs Product and Services
2.8.4 AbbVie Targeting DNA Repair Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.8.5 AbbVie Recent Developments/Updates
2.9 Johnson & Johnson
2.9.1 Johnson & Johnson Details
2.9.2 Johnson & Johnson Major Business
2.9.3 Johnson & Johnson Targeting DNA Repair Drugs Product and Services
2.9.4 Johnson & Johnson Targeting DNA Repair Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.9.5 Johnson & Johnson Recent Developments/Updates
2.10 Pfizer
2.10.1 Pfizer Details
2.10.2 Pfizer Major Business
2.10.3 Pfizer Targeting DNA Repair Drugs Product and Services
2.10.4 Pfizer Targeting DNA Repair Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.10.5 Pfizer Recent Developments/Updates
2.11 ClovisOncology
2.11.1 ClovisOncology Details
2.11.2 ClovisOncology Major Business
2.11.3 ClovisOncology Targeting DNA Repair Drugs Product and Services
2.11.4 ClovisOncology Targeting DNA Repair Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.11.5 ClovisOncology Recent Developments/Updates
2.12 GlaxoSmithKline
2.12.1 GlaxoSmithKline Details
2.12.2 GlaxoSmithKline Major Business
2.12.3 GlaxoSmithKline Targeting DNA Repair Drugs Product and Services
2.12.4 GlaxoSmithKline Targeting DNA Repair Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.12.5 GlaxoSmithKline Recent Developments/Updates
3 Competitive Environment: Targeting DNA Repair Drugs by Manufacturer
3.1 Global Targeting DNA Repair Drugs Sales Quantity by Manufacturer (2018-2023)
3.2 Global Targeting DNA Repair Drugs Revenue by Manufacturer (2018-2023)
3.3 Global Targeting DNA Repair Drugs Average Price by Manufacturer (2018-2023)
3.4 Market Share Analysis (2022)
3.4.1 Producer Shipments of Targeting DNA Repair Drugs by Manufacturer Revenue ($MM) and Market Share (%): 2022
3.4.2 Top 3 Targeting DNA Repair Drugs Manufacturer Market Share in 2022
3.4.2 Top 6 Targeting DNA Repair Drugs Manufacturer Market Share in 2022
3.5 Targeting DNA Repair Drugs Market: Overall Company Footprint Analysis
3.5.1 Targeting DNA Repair Drugs Market: Region Footprint
3.5.2 Targeting DNA Repair Drugs Market: Company Product Type Footprint
3.5.3 Targeting DNA Repair Drugs Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 Consumption Analysis by Region
4.1 Global Targeting DNA Repair Drugs Market Size by Region
4.1.1 Global Targeting DNA Repair Drugs Sales Quantity by Region (2018-2029)
4.1.2 Global Targeting DNA Repair Drugs Consumption Value by Region (2018-2029)
4.1.3 Global Targeting DNA Repair Drugs Average Price by Region (2018-2029)
4.2 North America Targeting DNA Repair Drugs Consumption Value (2018-2029)
4.3 Europe Targeting DNA Repair Drugs Consumption Value (2018-2029)
4.4 Asia-Pacific Targeting DNA Repair Drugs Consumption Value (2018-2029)
4.5 South America Targeting DNA Repair Drugs Consumption Value (2018-2029)
4.6 Middle East and Africa Targeting DNA Repair Drugs Consumption Value (2018-2029)
5 Market Segment by Type
5.1 Global Targeting DNA Repair Drugs Sales Quantity by Type (2018-2029)
5.2 Global Targeting DNA Repair Drugs Consumption Value by Type (2018-2029)
5.3 Global Targeting DNA Repair Drugs Average Price by Type (2018-2029)
6 Market Segment by Application
6.1 Global Targeting DNA Repair Drugs Sales Quantity by Application (2018-2029)
6.2 Global Targeting DNA Repair Drugs Consumption Value by Application (2018-2029)
6.3 Global Targeting DNA Repair Drugs Average Price by Application (2018-2029)
7 North America
7.1 North America Targeting DNA Repair Drugs Sales Quantity by Type (2018-2029)
7.2 North America Targeting DNA Repair Drugs Sales Quantity by Application (2018-2029)
7.3 North America Targeting DNA Repair Drugs Market Size by Country
7.3.1 North America Targeting DNA Repair Drugs Sales Quantity by Country (2018-2029)
7.3.2 North America Targeting DNA Repair Drugs Consumption Value by Country (2018-2029)
7.3.3 United States Market Size and Forecast (2018-2029)
7.3.4 Canada Market Size and Forecast (2018-2029)
7.3.5 Mexico Market Size and Forecast (2018-2029)
8 Europe
8.1 Europe Targeting DNA Repair Drugs Sales Quantity by Type (2018-2029)
8.2 Europe Targeting DNA Repair Drugs Sales Quantity by Application (2018-2029)
8.3 Europe Targeting DNA Repair Drugs Market Size by Country
8.3.1 Europe Targeting DNA Repair Drugs Sales Quantity by Country (2018-2029)
8.3.2 Europe Targeting DNA Repair Drugs Consumption Value by Country (2018-2029)
8.3.3 Germany Market Size and Forecast (2018-2029)
8.3.4 France Market Size and Forecast (2018-2029)
8.3.5 United Kingdom Market Size and Forecast (2018-2029)
8.3.6 Russia Market Size and Forecast (2018-2029)
8.3.7 Italy Market Size and Forecast (2018-2029)
9 Asia-Pacific
9.1 Asia-Pacific Targeting DNA Repair Drugs Sales Quantity by Type (2018-2029)
9.2 Asia-Pacific Targeting DNA Repair Drugs Sales Quantity by Application (2018-2029)
9.3 Asia-Pacific Targeting DNA Repair Drugs Market Size by Region
9.3.1 Asia-Pacific Targeting DNA Repair Drugs Sales Quantity by Region (2018-2029)
9.3.2 Asia-Pacific Targeting DNA Repair Drugs Consumption Value by Region (2018-2029)
9.3.3 China Market Size and Forecast (2018-2029)
9.3.4 Japan Market Size and Forecast (2018-2029)
9.3.5 Korea Market Size and Forecast (2018-2029)
9.3.6 India Market Size and Forecast (2018-2029)
9.3.7 Southeast Asia Market Size and Forecast (2018-2029)
9.3.8 Australia Market Size and Forecast (2018-2029)
10 South America
10.1 South America Targeting DNA Repair Drugs Sales Quantity by Type (2018-2029)
10.2 South America Targeting DNA Repair Drugs Sales Quantity by Application (2018-2029)
10.3 South America Targeting DNA Repair Drugs Market Size by Country
10.3.1 South America Targeting DNA Repair Drugs Sales Quantity by Country (2018-2029)
10.3.2 South America Targeting DNA Repair Drugs Consumption Value by Country (2018-2029)
10.3.3 Brazil Market Size and Forecast (2018-2029)
10.3.4 Argentina Market Size and Forecast (2018-2029)
11 Middle East & Africa
11.1 Middle East & Africa Targeting DNA Repair Drugs Sales Quantity by Type (2018-2029)
11.2 Middle East & Africa Targeting DNA Repair Drugs Sales Quantity by Application (2018-2029)
11.3 Middle East & Africa Targeting DNA Repair Drugs Market Size by Country
11.3.1 Middle East & Africa Targeting DNA Repair Drugs Sales Quantity by Country (2018-2029)
11.3.2 Middle East & Africa Targeting DNA Repair Drugs Consumption Value by Country (2018-2029)
11.3.3 Turkey Market Size and Forecast (2018-2029)
11.3.4 Egypt Market Size and Forecast (2018-2029)
11.3.5 Saudi Arabia Market Size and Forecast (2018-2029)
11.3.6 South Africa Market Size and Forecast (2018-2029)
12 Market Dynamics
12.1 Targeting DNA Repair Drugs Market Drivers
12.2 Targeting DNA Repair Drugs Market Restraints
12.3 Targeting DNA Repair Drugs Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
12.5 Influence of COVID-19 and Russia-Ukraine War
12.5.1 Influence of COVID-19
12.5.2 Influence of Russia-Ukraine War
13 Raw Material and Industry Chain
13.1 Raw Material of Targeting DNA Repair Drugs and Key Manufacturers
13.2 Manufacturing Costs Percentage of Targeting DNA Repair Drugs
13.3 Targeting DNA Repair Drugs Production Process
13.4 Targeting DNA Repair Drugs Industrial Chain
14 Shipments by Distribution Channel
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Targeting DNA Repair Drugs Typical Distributors
14.3 Targeting DNA Repair Drugs Typical Customers
15 Research Findings and Conclusion
16 Appendix
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer

Published By : GlobalInfoResearch

Why ‘The Market Reports’

In Business: Pre Sales Support: Post Sales Support: Turn Around Time: Clients Served: Clients Assisted: Client Types: Payment: Partners with: Number of reports: Custom Research: Report Availability: Report Delivery Format: Security:

Payments Accepted From

Connect with us at

Complete Secure Website

SiteLock